Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.

Serum drops for ocular surface disease: national survey of Canadian cornea specialists.

Marchand M, Harissi-Dagher M, Germain M, Thompson P, Robert MC.

Can J Ophthalmol. 2018 Jun;53(3):266-271. doi: 10.1016/j.jcjo.2017.09.007. Epub 2017 Nov 23.

PMID:
29784164
2.

No Light Perception Outcomes Following Boston Keratoprosthesis Type 1 Surgery.

Muzychuk AK, Durr GM, Shine JJ, Robert MC, Harissi-Dagher M.

Am J Ophthalmol. 2017 Sep;181:46-54. doi: 10.1016/j.ajo.2017.06.012. Epub 2017 Jun 27.

PMID:
28662941
3.

Mechanisms of Retinal Damage after Ocular Alkali Burns.

Paschalis EI, Zhou C, Lei F, Scott N, Kapoulea V, Robert MC, Vavvas D, Dana R, Chodosh J, Dohlman CH.

Am J Pathol. 2017 Jun;187(6):1327-1342. doi: 10.1016/j.ajpath.2017.02.005. Epub 2017 Apr 13.

4.

Sustained Subconjunctival Delivery of Infliximab Protects the Cornea and Retina Following Alkali Burn to the Eye.

Zhou C, Robert MC, Kapoulea V, Lei F, Stagner AM, Jakobiec FA, Dohlman CH, Paschalis EI.

Invest Ophthalmol Vis Sci. 2017 Jan 1;58(1):96-105. doi: 10.1167/iovs.16-20339.

5.

Corneal Melt after Boston Keratoprosthesis: Clinical Presentation, Management, Outcomes and Risk Factor Analysis.

Bouhout S, Robert MC, Deli S, Harissi-Dagher M.

Ocul Immunol Inflamm. 2018;26(5):693-699. doi: 10.1080/09273948.2016.1269930. Epub 2017 Jan 12.

PMID:
28080168
6.

Elevated Neutrophil Elastase in Tears of Ocular Graft-Versus-Host Disease Patients.

Arafat SN, Robert MC, Abud T, Spurr-Michaud S, Amparo F, Dohlman CH, Dana R, Gipson IK.

Am J Ophthalmol. 2017 Apr;176:46-52. doi: 10.1016/j.ajo.2016.12.026. Epub 2017 Jan 8.

PMID:
28073648
7.

Boston Keratoprosthesis Type 1: A Randomized Controlled Trial of Fresh versus Frozen Corneal Donor Carriers with Long-Term Follow-up.

Muzychuk AK, Robert MC, Dao S, Harissi-Dagher M.

Ophthalmology. 2017 Jan;124(1):20-26. doi: 10.1016/j.ophtha.2016.07.019. Epub 2016 Aug 24.

PMID:
27566854
8.

Tear Matrix Metalloproteinases and Myeloperoxidase Levels in Patients With Boston Keratoprosthesis Type I.

Robert MC, Arafat SN, Spurr-Michaud S, Chodosh J, Dohlman CH, Gipson IK.

Cornea. 2016 Jul;35(7):1008-14. doi: 10.1097/ICO.0000000000000893.

9.

Infliximab after Boston Keratoprosthesis in Stevens-Johnson Syndrome: An Update.

Robert MC, Črnej A, Shen LQ, Papaliodis GN, Dana R, Foster CS, Chodosh J, Dohlman CH.

Ocul Immunol Inflamm. 2017 Jun;25(3):413-417. doi: 10.3109/09273948.2016.1145237. Epub 2016 Mar 25.

PMID:
27015032
10.

A Drug Delivery System for Administration of Anti-TNF-α Antibody.

Robert MC, Frenette M, Zhou C, Yan Y, Chodosh J, Jakobiec FA, Stagner AM, Vavvas D, Dohlman CH, Paschalis EI.

Transl Vis Sci Technol. 2016 Mar 11;5(2):11. eCollection 2016 Mar.

11.

Avoidance of serious medical errors in refractive surgery using a custom preoperative checklist.

Robert MC, Choi CJ, Shapiro FE, Urman RD, Melki S.

J Cataract Refract Surg. 2015 Oct;41(10):2171-8. doi: 10.1016/j.jcrs.2015.10.060.

PMID:
26703293
12.

Evolution of Corneal Transplantation in the Province of Quebec From 2000 to 2011.

Robert MC, Choronzey ME, Lapointe J, Gauvin Meunier LP, Harissi-Dagher M, Germain M, Mabon M, Brunette I.

Cornea. 2015 Aug;34(8):880-7. doi: 10.1097/ICO.0000000000000481.

PMID:
26057325
13.

The Boston Keratoprosthesis type 1 as primary penetrating corneal procedure.

Fadous R, Levallois-Gignac S, Vaillancourt L, Robert MC, Harissi-Dagher M.

Br J Ophthalmol. 2015 Dec;99(12):1664-8. doi: 10.1136/bjophthalmol-2014-306161. Epub 2015 Jun 1.

PMID:
26034079
14.

Anterior chamber gas bubble emergence pattern during femtosecond LASIK-flap creation.

Robert MC, Khreim N, Todani A, Melki SA.

Br J Ophthalmol. 2015 Sep;99(9):1201-5. doi: 10.1136/bjophthalmol-2014-306307. Epub 2015 May 6.

PMID:
25947557
15.

Stability and in vitro toxicity of an infliximab eye drop formulation.

Robert MC, Spurr-Michaud S, Frenette M, Young D, Gipson IK, Dohlman CH.

Int J Pharm Compd. 2014 Sep-Oct;18(5):418-26.

PMID:
25577892
16.

A review of corneal melting after Boston Keratoprosthesis.

Robert MC, Dohlman CH.

Semin Ophthalmol. 2014 Sep-Nov;29(5-6):349-57. doi: 10.3109/08820538.2014.959186. Review.

PMID:
25325860
17.

Collagen cross-linking of the Boston keratoprosthesis donor carrier to prevent corneal melting in high-risk patients.

Robert MC, Arafat SN, Ciolino JB.

Eye Contact Lens. 2014 Nov;40(6):376-81. doi: 10.1097/ICL.0000000000000081. Review.

PMID:
25320957
18.

Long-term visual outcome of methylmalonic aciduria and homocystinuria, cobalamin C type.

Gizicki R, Robert MC, Gómez-López L, Orquin J, Decarie JC, Mitchell GA, Roy MS, Ospina LH.

Ophthalmology. 2014 Jan;121(1):381-386. doi: 10.1016/j.ophtha.2013.08.034. Epub 2013 Oct 11.

PMID:
24126030
19.

Endocanalicular laser dacryocystorhinostomy with mucosal flaps.

Robert MC, Maleki B, Boulos PR.

Ophthalmic Plast Reconstr Surg. 2013 Jul-Aug;29(4):294-7. doi: 10.1097/IOP.0b013e318295f903.

PMID:
23839636
20.

Fibrovascular ingrowth after 25-gauge transconjunctival vitrectomy in proliferative diabetic retinopathy.

Rezende FA, Qian CX, Robert MC.

Ophthalmic Surg Lasers Imaging Retina. 2013 Jul-Aug;44(4):405-8. doi: 10.3928/23258160-20130604-03. Epub 2013 Jun 12.

PMID:
23758324

Supplemental Content

Loading ...
Support Center